When AI designs a drug, who gets the credit?
Source:
mitTechReview
August 21, 2026 · 02:00
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
The original article opens on the publisher's website.
More from General
View topic →Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics
nytimes
Sep 1, 2026 · 16:57
Tim Cook to be paid $47mn as Apple’s executive chair
financialTimes
Sep 1, 2026 · 16:38
Are all TVs at risk from burn-in? Here's how to avoid the problem altogether
engadget
Sep 1, 2026 · 16:30
At G20 Meeting, Scott Bessent Accuses China of Flooding the World With Cheap Exports
nytimes
Sep 1, 2026 · 16:29
Will self-flying planes transform the skies?
bbcTechnology
Sep 1, 2026 · 16:27